{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:20:47Z","timestamp":1790871647303,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1023\/a:1020989812576","type":"journal-article","created":{"date-parts":[[2003,3,21]],"date-time":"2003-03-21T00:19:47Z","timestamp":1048205987000},"page":"1231-1243","source":"Crossref","is-referenced-by-count":55,"title":["Early and Late Gene Changes in MPTP Mice Model of Parkinson's Disease Employing cDNA Microarray"],"prefix":"10.1007","volume":"27","author":[{"given":"Silvia","family":"Mandel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna","family":"Gr\u00fcnblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gila","family":"Maor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moussa B. H.","family":"Youdim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"454323_CR1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H. Bernheimer","year":"1973","unstructured":"Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., and Seitelberger, F. 1973. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J. Neurol. Sci. 20:415-455.","journal-title":"J. Neurol. Sci."},{"key":"454323_CR2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","volume":"52","author":"P. Riederer","year":"1989","unstructured":"Riederer, P., Sofic, E., Rausch, W. D., Schmidt, B., Reynolds, G. P., Jellinger, K., and Youdim, M. B. H. 1989. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52:515-520.","journal-title":"J. Neurochem."},{"key":"454323_CR3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0304-3940(86)90474-X","volume":"70","author":"T. L. Perry","year":"1986","unstructured":"Perry, T. L., Yong, V. W., Jones, K., and Wright, J. M. 1986. Manipulation of glutathione contents fails to alter dopaminergic nigrostriatal neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse. Neurosci. Lett. 70:261-265.","journal-title":"Neurosci. Lett."},{"issue":"Suppl2","key":"454323_CR4","first-page":"II58","volume":"247","author":"E. C. Hirsch","year":"2000","unstructured":"Hirsch, E. C. 2000. Glial cells and Parkinson's disease. J. Neurol. 247 (Suppl 2): II58-II62.","journal-title":"J. Neurol."},{"key":"454323_CR5","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S1471-1931(00)00018-5","volume":"23","author":"T. N. Chase","year":"2000","unstructured":"Chase, T. N. and Oh, J. D. 2000. Striatal dopamine-and glutamate-mediated dysregulation in experimental parkinsonism. Trends Neurosci. 23:S86-S91.","journal-title":"Trends Neurosci."},{"key":"454323_CR6","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1074\/jbc.M010907200","volume":"276","author":"V. N. Uversky","year":"2001","unstructured":"Uversky, V. N., Li, J., and Fink, A. L. 2001. Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J. Biol. Chem. 276:10737-10744.","journal-title":"J. Biol. Chem."},{"key":"454323_CR7","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1073\/pnas.94.14.7531","volume":"94","author":"S. Hunot","year":"1997","unstructured":"Hunot, S., Brugg, B., Ricard, D., Michel, P. P., Muriel, M. P., Ruberg, M., Faucheux, B. A., Agid, Y., and Hirsch, E. C. 1997. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. Proc. Natl. Acad. Sci. USA 94:7531-7536.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"454323_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF01345237","volume":"14","author":"L. D. Loopuijt","year":"1998","unstructured":"Loopuijt, L. D. and Schmidt, W. J. 1998. The role of NMDA receptors in the slow neuronal degeneration of Parkinson's disease. Amino Acids 14:17-23.","journal-title":"Amino Acids"},{"key":"454323_CR9","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1073\/pnas.87.11.4078","volume":"87","author":"A. M. Iacopino","year":"1990","unstructured":"Iacopino, A. M. and Christakos, S. 1990. Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 87:4078-4082.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"454323_CR10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1212\/WNL.46.3.791","volume":"46","author":"Y. Nagai","year":"1996","unstructured":"Nagai, Y., Ueno, S., Saeki, Y., Soga, F., Hirano, M., and Yanagihara, T. 1996. Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease. Neurology 46:791-795.","journal-title":"Neurology"},{"key":"454323_CR11","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1471-4159.1991.tb11444.x","volume":"56","author":"D. Ben-Shachar","year":"1991","unstructured":"Ben-Shachar, D., Eshel, G., Finberg, J. P., and Youdim, M. B. 1991. The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons. J. Neurochem. 56:1441-1444.","journal-title":"J. Neurochem."},{"key":"454323_CR12","volume-title":"Neurodegeneration and neuroprotection in Parkinson's disease","author":"C. W. Olanow","year":"1996","unstructured":"Olanow, C. W. 1996. Neurodegeneration and neuroprotection in Parkinson's disease. New York, Academic Press."},{"key":"454323_CR13","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/1531-8257(199907)14:4<612::AID-MDS1010>3.0.CO;2-6","volume":"14","author":"E. Grunblatt","year":"1999","unstructured":"Grunblatt, E., Mandel, S., Berkuzki, T., and Youdim, M. B. H. 1999. Apomorphine protects against MPTP-induced neurotoxicity in mice. Mov. Disord. 14:612-618.","journal-title":"Mov. Disord."},{"key":"454323_CR14","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1046\/j.1471-4159.2001.00490.x","volume":"78","author":"Y. Levites","year":"2001","unstructured":"Levites, Y., Weinreb, O., Maor, G., Youdim, M. B. H., and Mandel, S. 2001. Green tea polyphenol (-)-Epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J. Neurochem. 78:1073-1082.","journal-title":"J. Neurochem."},{"key":"454323_CR15","first-page":"83","volume":"Suppl","author":"M. B. H. Youdim","year":"2000","unstructured":"Youdim, M. B. H., Gassen, M., Gross, A., Mandel, S., and Grunblatt, E. 2000. Iron chelating, antioxidant and cytoprotective properties of dopamine receptor agonist; apomorphine. J. Neural. Transm. Suppl:83-96.","journal-title":"J. Neural. Transm."},{"key":"454323_CR16","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","volume":"22","author":"D. C. Wu","year":"2002","unstructured":"Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D. K., Ischiropoulos, H., and Przedborski, S. 2002. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 22:1763-1771.","journal-title":"J. Neurosci."},{"key":"454323_CR17","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/00001756-200004270-00024","volume":"11","author":"P. Klivenyi","year":"2000","unstructured":"Klivenyi, P., Andreassen, O. A., Ferrante, R. J., Lancelot, E., Reif, D., and Beal, M. F. 2000. Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity. Neuroreport 11:1265-1268.","journal-title":"Neuroreport"},{"key":"454323_CR18","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1046\/j.0953-816x.2001.01542.x","volume":"13","author":"X. Guo","year":"2001","unstructured":"Guo, X., Dawson, V. L., and Dawson, T. M. 2001. Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons. Eur. J. Neurosci. 13:1683-1693.","journal-title":"Eur. J. Neurosci."},{"key":"454323_CR19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-2999(00)00939-0","volume":"413","author":"D. Maimone","year":"2001","unstructured":"Maimone, D., Dominici, R., and Grimaldi, L. M. 2001. Pharmacogenomics of neurodegenerative diseases. Eur. J. Pharmacol. 413:11-29.","journal-title":"Eur. J. Pharmacol."},{"key":"454323_CR20","unstructured":"Deleted in proof."},{"key":"454323_CR21","first-page":"117","volume":"60","author":"S. Mandel","year":"2000","unstructured":"Mandel, S., Grunblatt, E., and Youdim, M. B. H. 2000. cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: Implications for idiopathic Parkinson's disease. J. Neural. Transm. Suppl. 60:117-124.","journal-title":"J. Neural. Transm. Suppl."},{"key":"454323_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2001.00397.x","volume":"78","author":"E. Grunblatt","year":"2001","unstructured":"Grunblatt, E., Mandel, S., Maor, G., and Youdim, M. B. H. 2001. Gene expression analysis in MPTP mice model of Parkinson's disease using cDNA microarray. J. Neurochem. 78:1-12.","journal-title":"J. Neurochem."},{"key":"454323_CR23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/(SICI)1097-4547(20000101)59:1<126::AID-JNR15>3.0.CO;2-L","volume":"59","author":"J. A. Cochiolo","year":"2000","unstructured":"Cochiolo, J. A., Ehsanian, R., and Bruck, D. K. 2000. Acute ultrastructural effects of MPTP on the nigrostriatal pathway of the C57BL\/6 adult mouse: Evidence of compensatory plasticity in nigrostriatal neurons. J. Neurosci. Res. 59:126-135.","journal-title":"J. Neurosci. Res."},{"key":"454323_CR24","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0022-3565(25)39602-3","volume":"267","author":"P. Chan","year":"1993","unstructured":"Chan, P., Langston, J. W., and Di Monte, D. A. 1993. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP1 elimination in the mouse striatum. J. Pharmacol. Exp. Ther. 267:1515-1520.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"454323_CR25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0028-3908(88)90120-7","volume":"27","author":"A. Studer","year":"1988","unstructured":"Studer, A., Sundstrom, E., Jonsson, G., and Schultz, W. 1988. Acute electrophysiological and neurochemical effects of administration of MPTP in mice. Neuropharmacology 27:923-931.","journal-title":"Neuropharmacology"},{"key":"454323_CR26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0304-3940(88)90786-0","volume":"90","author":"S. Mori","year":"1988","unstructured":"Mori, S., Fujitake, J., Kuno, S., and Sano, Y. 1988. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies. Neurosci. Lett. 90:57-62.","journal-title":"Neurosci. Lett."},{"key":"454323_CR27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0922-4106(89)90023-0","volume":"172","author":"J. Garthwaite","year":"1989","unstructured":"Garthwaite, J., Garthwaite, G., Palmer, R. M., and Moncada, S. 1989. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol. 172:413-416.","journal-title":"Eur. J. Pharmacol."},{"key":"454323_CR28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/niox.1997.0144","volume":"1","author":"S. M. Sequeira","year":"1997","unstructured":"Sequeira, S. M., Ambrosio, A. F., Malva, J. O., Carvalho, A. P., and Carvalho, C. M. 1997. Modulation of glutamate release from rat hippocampal synaptosomes by nitric oxide. Nitric Oxide 1:315-329.","journal-title":"Nitric Oxide"},{"key":"454323_CR29","first-page":"157","volume-title":"Free radicals in brain pathophysiology","author":"A. P. Carvalho","year":"2000","unstructured":"Carvalho, A. P., Sequeira, S. M., Duarte, C. B., and Carvalho, A. P. 2000. Pages 157-176, in Free radicals in brain pathophysiology (Giuseppe, P., Enrique, C., and Lester, P., eds), Marcel Dekker Inc., New York."},{"key":"454323_CR30","first-page":"141","volume":"14","author":"T. V. Ilic","year":"1999","unstructured":"Ilic, T. V., Jovanovic, M., Jovicic, A., and Tomovic, M. 1999. Oxidative stress indicators are elevated in de novo Parkinson's disease patients. Funct. Neurol. 14:141-147.","journal-title":"Funct. Neurol."},{"key":"454323_CR31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0006-8993(96)00003-0","volume":"716","author":"J. E. Barker","year":"1996","unstructured":"Barker, J. E., Heales, S. J., Cassidy, A., Bolanos, J. P., Land, J. M., and Clark, J. B. 1996. Depletion of brain glutathione results in a decrease of glutathione reductase activity; an enzyme susceptible to oxidative damage. Brain Res. 716:118-122.","journal-title":"Brain Res."},{"key":"454323_CR32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0925-4439(97)00070-7","volume":"1362","author":"D. S. Cassarino","year":"1997","unstructured":"Cassarino, D. S., Fall, C. P., Swerdlow, R. H., Smith, T. S., Halvorsen, E. M., Miller, S. W., Parks, J. P., Parker, W. D., Jr., and Bennett, J. P., Jr. 1997. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim. Biophys. Acta 1362:77-86.","journal-title":"Biochim. Biophys. Acta"},{"key":"454323_CR33","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0891-5849(98)00076-8","volume":"25","author":"J. S. Kim-Han","year":"1998","unstructured":"Kim-Han, J. S. and Sun, A. Y. 1998. Protection of PC12 cells glutathione peroxidase in L-DOPA induced cytotoxicity. Free Radic. Biol. Med. 25:512-518.","journal-title":"Free Radic. Biol. Med."},{"key":"454323_CR34","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1046\/j.1460-9568.1998.00345.x","volume":"10","author":"J. C. Bensadoun","year":"1998","unstructured":"Bensadoun, J. C., Mirochnitchenko, O., Inouye, M., Aebischer, P., and Zurn, A. D. 1998. Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice. Eur. J. Neurosci. 10:3231-3236.","journal-title":"Eur. J. Neurosci."},{"key":"454323_CR35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0304-3940(96)12706-3","volume":"211","author":"M. Mogi","year":"1996","unstructured":"Mogi, M., Harada, M., Narabayashi, H., Inagaki, H., Minami, M., and Nagatsu, T. 1996. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. Neurosci. Lett. 211:13-16.","journal-title":"Neurosci. Lett."},{"key":"454323_CR36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(98)00427-3","volume":"250","author":"M. Mogi","year":"1998","unstructured":"Mogi, M., Togari, A., Ogawa, M., Ikeguchi, K., Shizuma, N., Fan, D., Nakano, I., and Nagatsu, T. 1998. Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1 beta and nerve growth factor in the striatum. Neurosci. Lett. 250:25-28.","journal-title":"Neurosci. Lett."},{"key":"454323_CR37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0753-3322(99)80079-1","volume":"53","author":"H. Bessler","year":"1999","unstructured":"Bessler, H., Djaldetti, R., Salman, H., Bergman, M., and Djaldetti, M. 1999. IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson's disease. Biomed. Pharmacother. 53:141-145.","journal-title":"Biomed. Pharmacother."},{"key":"454323_CR38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0531-5565(00)00118-2","volume":"35","author":"Y. Lavrovsky","year":"2000","unstructured":"Lavrovsky, Y., Chatterjee, B., Clark, R. A., and Roy, A. K. 2000. Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp. Gerontol. 35:521-532.","journal-title":"Exp. Gerontol."},{"key":"454323_CR39","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF02252926","volume":"2","author":"K. Jellinger","year":"1990","unstructured":"Jellinger, K., Paulus, W., Grundke-Iqbal, I., Riederer, P., and Youdim, M. B. H. 1990. Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J. Neural. Transm. Park. Dis. Dement. Sect. 2:327-340.","journal-title":"J. Neural. Transm. Park. Dis. Dement. Sect."},{"key":"454323_CR40","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/j.1460-2075.1991.tb07761.x","volume":"10","author":"R. Schreck","year":"1991","unstructured":"Schreck, R., Rieber, P., and Baeuerle, P. A. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10:2247-2258.","journal-title":"EMBO J."},{"key":"454323_CR41","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1002\/eji.1830251108","volume":"25","author":"G. M. Crisi","year":"1995","unstructured":"Crisi, G. M., Santambrogio, L., Hochwald, G. M., Smith, S. R., Carlino, J. A., and Thorbecke, G. J. 1995. Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: Protection by transforming growth factor-beta and interleukin-10. Eur. J. Immunol. 25:3035-3040.","journal-title":"Eur. J. Immunol."},{"key":"454323_CR42","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1523\/JNEUROSCI.16-09-02945.1996","volume":"16","author":"V. Balasingam","year":"1996","unstructured":"Balasingam, V. and Yong, V. W. 1996. Attenuation of astroglial reactivity by interleukin-10. J. Neurosci. 16:2945-2955.","journal-title":"J. Neurosci."},{"key":"454323_CR43","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.4049\/jimmunol.157.11.5185","volume":"157","author":"U. Koedel","year":"1996","unstructured":"Koedel, U., Bernatowicz, A., Frei, K., Fontana, A., and Pfister, H. W. 1996. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis. J. Immunol. 157:5185-5191.","journal-title":"J. Immunol."},{"key":"454323_CR44","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1006\/exnr.1999.7173","volume":"159","author":"K. L. Brewer","year":"1999","unstructured":"Brewer, K. L., Bethea, J. R., and Yezierski, R. P. 1999. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Exp. Neurol. 159:484-493.","journal-title":"Exp. Neurol."},{"key":"454323_CR45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0304-3940(90)90131-R","volume":"117","author":"S. Carboni","year":"1990","unstructured":"Carboni, S., Melis, F., Pani, L., Hadjiconstantinou, M., and Rossetti, Z. L. 1990. The non-competitive NMDA-receptor antagonist MK-801 prevents the massive release of glutamate and aspartate from rat striatum induced by 1-methyl-4-phenylpyridinium (MPP1). Neurosci. Lett. 117:129-133.","journal-title":"Neurosci. Lett."},{"key":"454323_CR46","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1073\/pnas.88.14.6368","volume":"88","author":"V. L. Dawson","year":"1991","unstructured":"Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S., and Snyder, S. H. 1991. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA 88:6368-6371.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"454323_CR47","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0896-6273(92)90130-6","volume":"8","author":"S. Z. Lei","year":"1992","unstructured":"Lei, S. Z., Pan, Z. H., Aggarwal, S. K., Chen, H. S., Hartman, J., Sucher, N. J., and Lipton, S. A. 1992. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 8:1087-1099.","journal-title":"Neuron"},{"key":"454323_CR48","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/364626a0","volume":"364","author":"S. A. Lipton","year":"1993","unstructured":"Lipton, S. A., Choi, Y. B., Pan, Z. H., Lei, S. Z., Chen, H. S., Sucher, N. J., Loscalzo, J., Singel, D. J., and Stamler, J. S. 1993. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-632.","journal-title":"Nature"},{"key":"454323_CR49","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0026-895X(25)08772-3","volume":"47","author":"L. Fagni","year":"1995","unstructured":"Fagni, L., Olivier, M., Lafon-Cazal, M., and Bockaert, J. 1995. Involvement of divalent ions in the nitric oxide-induced blockade of N-methyl-D-aspartate receptors in cerebellar granule cells. Mol. Pharmacol. 47:1239-1247.","journal-title":"Mol. Pharmacol."},{"key":"454323_CR50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/niox.1997.0118","volume":"1","author":"K. D. Kroncke","year":"1997","unstructured":"Kroncke, K. D., Fehsel, K., and Kolb-Bachofen, V. 1997. Nitric oxide: Cytotoxicity versus cytoprotection-how, why, when, and where? Nitric Oxide 1:107-120.","journal-title":"Nitric Oxide"},{"key":"454323_CR51","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1054\/mehy.1997.0680","volume":"52","author":"A. McShea","year":"1999","unstructured":"McShea, A., Wahl, A. F., and Smith, M. A. 1999. Re-entry into the cell cycle: A mechanism for neurodegeneration in Alzheimer disease. Med. Hypotheses 52:525-527.","journal-title":"Med. Hypotheses"},{"key":"454323_CR52","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/1097-4547(20000715)61:2<128::AID-JNR2>3.0.CO;2-H","volume":"61","author":"A. K. Raina","year":"2000","unstructured":"Raina, A. K., Zhu, X., Rottkamp, C. A., Monteiro, M., Takeda, A., and Smith, M. A. 2000. Cyclin' toward dementia: Cell cycle abnormalities and abortive oncogenesis in Alzheimer disease. J. Neurosci. Res. 61:128-133.","journal-title":"J. Neurosci. Res."},{"key":"454323_CR53","doi-asserted-by":"crossref","first-page":"30574","DOI":"10.1074\/jbc.M202832200","volume":"277","author":"Y. Levites","year":"2002","unstructured":"Levites, Y., Amit, T., Youdim, M. B. H., and Mandel, S. 2002. Involvement of protein kinase C activation and cell survival\/cell cycle genes in green tea polyphenol (-)-epigallocatechin-3-gallate neuroprotective action. J. Biol. Chem. 277:30574-30580.","journal-title":"J. Biol. Chem."},{"key":"454323_CR54","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1471-4159.1991.tb03776.x","volume":"57","author":"M. Hadjiconstantinou","year":"1991","unstructured":"Hadjiconstantinou, M., Fitkin, J. G., Dalia, A., and Neff, N. H. 1991. Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse. J. Neurochem. 57:479-482.","journal-title":"J. Neurochem."},{"key":"454323_CR55","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.8493557","volume":"260","author":"L. F. Lin","year":"1993","unstructured":"Lin, L. F., Doherty, D. H., Lile, J. D., Bektesh, S., and Collins, F. 1993. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons [see comments]. Science 260: 1130-1132.","journal-title":"Science"},{"key":"454323_CR56","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/BF01291789","volume":"103","author":"S. Hunot","year":"1996","unstructured":"Hunot, S., Bernard, V., Faucheux, B., Boissiere, F., Leguern, E., Brana, C., Gautris, P. P., Guerin, J., Bloch, B., Agid, Y., and Hirsch, E. C. 1996. Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: A post mortem in situ hybridization study with special reference to Parkinson's disease. J. Neural. Transm. (Budapest) 103:1043-1052.","journal-title":"J. Neural. Transm. (Budapest)"},{"key":"454323_CR57","first-page":"S121","volume":"44","author":"D. M. Gash","year":"1998","unstructured":"Gash, D. M., Zhang, Z., and Gerhardt, G. 1998. Neuroprotective and neurorestorative properties of GDNF. Ann. Neurol. 44:S121-S125.","journal-title":"Ann. Neurol."},{"key":"454323_CR58","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/bbrc.1997.6221","volume":"232","author":"T. Ishii","year":"1997","unstructured":"Ishii, T., Yanagawa, T., Yuki, K., Kawane, T., Yoshida, H., and Bannai, S. 1997. Low micromolar levels of hydrogen peroxide and proteasome inhibitors induce the 60-kDa A170 stress protein in murine peritoneal macrophages. Biochem. Biophys. Res. Commun. 232:33-37.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"454323_CR59","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1523\/JNEUROSCI.22-01-00274.2002","volume":"22","author":"T. Xie","year":"2002","unstructured":"Xie, T., Tong, L., Barrett, T., Yuan, J., Hatzidimitriou, G., Mc-Cann, U. D., Becker, K. G., Donovan, D. M., and Ricaurte, G. A. 2002. Changes in gene expression linked to methamphetamine-induced dopaminergic neurotoxicity. J. Neurosci. 22:274-283.","journal-title":"J. Neurosci."},{"key":"454323_CR60","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/syn.1058","volume":"41","author":"J. L. Cadet","year":"2001","unstructured":"Cadet, J. L., Jayanthi, S., McCoy, M. T., Vawter, M., and Ladenheim, B. 2001. Temporal profiling of methamphetamine-induced changes in gene expression in the mouse brain: Evidence from cDNA array. Synapse 41:40-48.","journal-title":"Synapse"},{"key":"454323_CR61","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1471-4159.1996.67020443.x","volume":"67","author":"S. C. Kumer","year":"1996","unstructured":"Kumer, S. C. and Vrana, K. E. 1996. Intricate regulation of tyrosine hydroxylase activity and gene expression. J. Neurochem. 67:443-462.","journal-title":"J. Neurochem."},{"key":"454323_CR62","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1046\/j.1471-4159.2000.0751200.x","volume":"75","author":"M. S. Saporito","year":"2000","unstructured":"Saporito, M. S., Thomas, B. A., and Scott, R. W. 2000. MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo. J. Neurochem. 75:1200-1208.","journal-title":"J. Neurochem."},{"key":"454323_CR63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1353-8020(00)00078-X","volume":"8","author":"T. Gearan","year":"2001","unstructured":"Gearan, T., Castillo, O. A., and Schwarzschild, M. A. 2001. The parkinsonian neurotoxin, MPP(1) induces phosphorylated c-Jun in dopainergric neurons of mesencephalic cultures. Parkinsonism Relat. Disord. 8:19-22.","journal-title":"Parkinsonism Relat. Disord."},{"key":"454323_CR64","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T. Kitada","year":"1998","unstructured":"Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., and Shimizu, N. 1998. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism [see comments]. Nature 392:605-608.","journal-title":"Nature"},{"key":"454323_CR65","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z","volume":"45","author":"H. Shimura","year":"1999","unstructured":"Shimura, H., Hattori, N., Kubo, S., Yoshikawa, M., Kitada, T., Matsumine, H., Asakawa, S., Minoshima, S., Yamamura, Y., Shimizu, N., and Mizuno, Y. 1999. Immunohistochemical and subcellular localization of Parkin protein: Absence of protein in autosomal recessive juvenile parkinsonism patients. Ann. Neurol. 45:668-672.","journal-title":"Ann. Neurol."},{"key":"454323_CR66","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(01)02281-9","volume":"314","author":"J. Y. Chen","year":"2001","unstructured":"Chen, J. Y., Hsu, P. C., Hsu, I. L., and Yeh, G. C. 2001. Sequential up-regulation of the c-fos, c-jun and bax genes in the cortex, striatum and cerebellum induced by a single injection of a low dose of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in C57BL\/6 mice. Neurosci. Lett. 314:49-52.","journal-title":"Neurosci. Lett."},{"key":"454323_CR67","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1073\/pnas.95.13.7659","volume":"95","author":"J. Ara","year":"1998","unstructured":"Ara, J., Przedborski, S., Naini, A. B., Jackson-Lewis, V., Trifiletti, R. R., Horwitz, J., and Ischiropoulos, H. 1998. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc. Natl. Acad. Sci. USA 95:7659-7663.","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1020989812576.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1020989812576\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1020989812576.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T05:26:08Z","timestamp":1751865968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1020989812576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":67,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["454323"],"URL":"https:\/\/doi.org\/10.1023\/a:1020989812576","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}